Evidence map›Paper›PMID 36276383›Full record

ArticleFrontiers in public health2022

Guiding the design of SARS-CoV-2 genomic surveillance by estimating the resolution of outbreak detection.

Carl J E Suster, Alicia Arnott, Grace Blackwell, Mailie Gall, Jenny Draper, Elena Martinez, Alexander P Drew, Rebecca J Rockett, Sharon C-A Chen, Jen Kok and 2 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carl J E SusterCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.
Alicia ArnottCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.
Grace BlackwellSydney Institute for Infectious Diseases, The University of Sydney, Westmead, NSW, Australia.
Mailie GallSydney Institute for Infectious Diseases, The University of Sydney, Westmead, NSW, Australia.
Jenny DraperSydney Institute for Infectious Diseases, The University of Sydney, Westmead, NSW, Australia.
Elena MartinezSydney Institute for Infectious Diseases, The University of Sydney, Westmead, NSW, Australia.
Alexander P DrewSydney Institute for Infectious Diseases, The University of Sydney, Westmead, NSW, Australia.
Rebecca J RockettCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.
Sharon C-A ChenCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.
Jen KokCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.
Dominic E DwyerCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.
Vitali SintchenkoCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Westmead, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic surveillance of SARS-CoV-2 has been essential to inform public health response to outbreaks. The high incidence of infection has resulted in a smaller proportion of cases undergoing whole genome sequencing due to finite resources. We present a framework for estimating the impact of reduced depths of genomic surveillance on the resolution of outbreaks, based on a clustering approach using pairwise genetic and temporal distances. We apply the framework to simulated outbreak data to show that outbreaks are detected less frequently when fewer cases are subjected to whole genome sequencing. The impact of sequencing fewer cases depends on the size of the outbreaks, and on the genetic and temporal similarity of the index cases of the outbreaks. We also apply the framework to an outbreak of the SARS-CoV-2 Delta variant in New South Wales, Australia. We find that the detection of clusters in the outbreak would have been delayed if fewer cases had been sequenced. Existing recommendations for genomic surveillance estimate the minimum number of cases to sequence in order to detect and monitor new virus variants, assuming representative sampling of cases. Our method instead measures the resolution of clustering, which is important for genomic epidemiology, and accommodates sampling biases.

Indexed as

COVID-19SARS-CoV-2Disease OutbreaksGenomicsHumansgenomic surveillanceoutbreak detectionpathogen genomicspublic healthSARS-CoV-2

Identifiers

PMID36276383
PMCPMC9581317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.